Fundz

Mithrl raises $20 million in a Series A round led by Obvious Ventures to advance its custom AI infrastructure for biopharma.

PRIVATESep 15, 2026

Amount Raised

$20 Million

Round Type

Series A

San FranciscoBiotechnologyArtificial IntelligenceMachine Learning

Investors

HeadlineAgi HouseObvious Ventures

Description

Mithrl, the AI infrastructure company for biopharma, announced a $20 million Series A round. The funding, led by Obvious Ventures and supported by other investors, will enhance Mithrl's second-generation platform. This platform utilizes a proprietary biomedical world model integrated with advanced AI technologies. The goal is to optimize AI infrastructure in the biopharmaceutical sector.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Mithril Medicine that raised within 45 days of this round, from Fundz verified event records.

  • VUSE XR raised $1.3M (Pre-Seed) on October 29, 2026.
  • Albert raised an undisclosed amount on October 26, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • Empirical Machines raised $20M on October 17, 2026.
  • Albert Invent raised $55M (Series B) on October 13, 2026.
  • NuSynth Technologies raised $3.8M (Seed) on October 13, 2026.

Who to call at Mithril Medicine, and when

A new round usually means Mithril Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mithril Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mithril Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mithril Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mithril Medicine

Location

San Francisco, California, United States

About

Mithril Medicine is a one-man stealth drug discovery startup run by a pseudonymous Twitter poster.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mithril Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsShara, Chief Technology Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Mithril Medicine's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Mithril Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.